Skip to search formSkip to main contentSkip to account menu

Advagraf

Known as: Avagraf 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Anhydrous Tacrolimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Randomized open‐label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas‐kidney patients
We assessed the pharmacokinetic and pharmacodynamic impact of converting stable simultaneous pancreas‐kidney (SPK) recipients… 
2014
2014
Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol.
2013
2013
Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up
BackgroundThe conversion from Prograf to Advagraf on a 1:1 (mg:mg) basis has been questioned in light of the publication of… 
2013
2013
Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem…
Abstract A dose ratio of 1:1 was recommended for the conversion from Standard-release Tacrolimus (Prograf) to Prolonged-release… 
2012
2012
The once-daily formulation of tacrolimus: a step forward in kidney transplantation?
Nonadherence is a critical issue in transplantation. Recently, Astellas designed a once-daily-extended release formulation of… 
2012
2012
Immunosuppression with tacrolimus early after orthotopic heart transplantation: a comparison of prograf and advagraf.
BACKGROUND We compared trough levels and clinical outcomes in patients who received Prograf or Advagraf (tacrolimus) de novo… 
Review
2011
Review
2011
Conversion From Prograf to Advagraf Among Kidney Transplant Recipients Results in Sustained Decrease in Tacrolimus Exposure
Background. Advagraf is a slow release form of tacrolimus with once-daily formulation. The potential advantages of Advagraf are… 
2010
2010
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
2010
2010
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
2009
2009
Modified release tacrolimus in de novo immunosuppression after simultaneous pancreas-kidney transplantation--a first single-center experience.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)